(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Here's what can happen if you drive under the influence of pot - 2Kelsey Grammer on having a new baby at 70: 'You're just more available now'
- 3In the background: Visiting Notable Film Areas All over the Planet
- 4Party Urban areas of the World
- 5Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- Watch Rocket Lab launch Japanese technology-demonstrating satellite to orbit tonight
- These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- New method spots signs of Earth's primordial life in ancient rocks
- Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget
- Architect Frank Gehry has died: See his most iconic buildings
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- Ultra-Orthodox protests erupt across Israel on haredi IDF enlistment day
- Pick Your #1 Kind Of Bread
- Vote in favor of the Top Vegetable for Senior
